Drug Interaction Study With Rosuvastatin

NCT02101125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunosuppression For Disease

Interventions

DRUG: BMS-986020
DRUG: Rosuvastatin

Sponsor

Bristol-Myers Squibb